Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema.

[1]  M. López-Trascasa,et al.  Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. , 2008, The Journal of allergy and clinical immunology.

[2]  S. Cichon,et al.  Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. , 2006, American journal of human genetics.

[3]  Q. Duan,et al.  Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. , 2006, Kidney international.

[4]  K. Bork,et al.  Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.

[5]  M. Rafii,et al.  Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke , 2005, Neurology.

[6]  J. Rouleau,et al.  A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. , 2005, American journal of human genetics.

[7]  J. Strong,et al.  ACE insert/delete polymorphism and atherosclerosis. , 2005, Atherosclerosis.

[8]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[9]  Y. Ikeda,et al.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion , 2004, Human Genetics.

[10]  M. Whitehead,et al.  Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers , 2004, British journal of haematology.

[11]  K. Binkley,et al.  Estrogen-dependent inherited angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[12]  A. Davis.  The pathogenesis of hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[13]  Laurence Klotz.  Reactions , 2002, The Lancet.

[14]  M. Cicardi,et al.  Bradykinin-mediated angioedema. , 2002, The New England journal of medicine.

[15]  M. Kurabayashi,et al.  Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women , 2001, Menopause.

[16]  J. Rouleau,et al.  Bradykinin metabolism and hypotensive transfusion reactions , 2001, Transfusion.

[17]  K. Bork,et al.  Hereditary angioedema and normal C1-inhibitor activity in women , 2000, The Lancet.

[18]  K. Binkley,et al.  Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.

[19]  J. Morrow,et al.  Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite. , 2000, The Journal of pharmacology and experimental therapeutics.

[20]  T. Kanda,et al.  Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin. , 1999 .

[21]  J. Rouleau,et al.  Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. , 1999, Immunopharmacology.

[22]  M. Cicardi,et al.  Idiopathic nonhistaminergic angioedema. , 1999, The American journal of medicine.

[23]  P. Thibault,et al.  Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P , 1999, Peptides.

[24]  B. Stricker,et al.  ACE Inhibitor-Induced Angioedema , 1998, Drug safety.

[25]  A. Sacchi,et al.  Molecular basis of estrogen regulation of Hageman factor XII gene expression. , 1995, Endocrinology.

[26]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[27]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[28]  B. O’Malley,et al.  Specific binding of estrogen receptor to the estrogen response element , 1989, Molecular and cellular biology.

[29]  R. Champion,et al.  URTICARIA AND ANGIO‐OEDEMA , 1969, The British journal of dermatology.

[30]  M. Kurabayashi,et al.  Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[31]  D. Proud,et al.  Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.

[32]  A. Davis.  C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.